Table 5.
Pharmacists’ perceived system-related barriers to provision of HPV vaccine, Number (%) a.
| Statement on System Barriers b | Not at All | A Little | Moderate | Very | Extremely |
|---|---|---|---|---|---|
| There are too few patients who want the HPV vaccine. (N = 147) | 15 (10.2) | 23 (15.6) | 26 (17.7) | 46 (31.3) | 37 (25.2) |
| The failure of some insurance companies to cover the cost of vaccination. (N = 146) | 20 (13.7) | 14 (9.6) | 32 (21.9) | 46 (31.5) | 34 (23.3) |
| The vaccine expiring before use. (N = 148) | 24 (16.2) | 18 (12.2) | 26 (17.6) | 43 (29.1) | 37 (25.0) |
| The difficulty ensuring patients are completing the necessary 3 doses of the HPV vaccine. (N = 148) | 25 (16.9) | 26 (17.6) | 38 (25.7) | 39 (26.4) | 20 (13.5) |
| The lack of adequate reimbursement for the HPV vaccination. (N = 146) | 31 (21.2) | 26 (17.8) | 33 (22.6) | 34 (23.3) | 22 (15.1) |
| The cost of stocking the HPV vaccine. (N = 147) | 42 (28.6) | 27 (18.4) | 29 (19.7) | 34 (23.1) | 15 (20.2) |
| The need to acquire a prescription from a physician to administer the HPV vaccine. (N = 147) | 54 (36.7) | 25 (17.0) | 35 (23.8) | 24 (16.3) | 9 (6.1) |
| The amount of time it takes to talk to patients and/or parents about the HPV vaccine. (N = 147) | 69 (46.9) | 27 (18.4) | 29 (19.7) | 18 (12.2) | 4 (2.7) |
| The refrigerator space needed to store the HPV vaccine. (N = 147) | 90 (61.2) | 27 (18.4) | 20 (13.6) | 9 (6.1) | 1 (0.7) |
a The most frequently chosen responses/answers are bold for each question; b Respondents rated how likely each factor was to be a barrier in providing HPV vaccination services.